Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 134

2.

Theophylline for prevention of contrast-induced nephropathy: a systematic review and meta-analysis.

Bagshaw SM, Ghali WA.

Arch Intern Med. 2005 May 23;165(10):1087-93. Review.

PMID:
15911721
3.

N-acetylcysteine for the prevention of radiocontrast induced nephropathy: a meta-analysis of prospective controlled trials.

Kshirsagar AV, Poole C, Mottl A, Shoham D, Franceschini N, Tudor G, Agrawal M, Denu-Ciocca C, Magnus Ohman E, Finn WF.

J Am Soc Nephrol. 2004 Mar;15(3):761-9. Review.

5.

N-acetylcysteine: short-term clinical benefits after coronary angiography in high-risk renal patients.

Carbonell N, Sanjuán R, Blasco M, Jordá A, Miguel A.

Rev Esp Cardiol. 2010 Jan;63(1):12-9.

6.

N-acetylcysteine and contrast-induced nephropathy: a meta-analysis of 13 randomized trials.

Zagler A, Azadpour M, Mercado C, Hennekens CH.

Am Heart J. 2006 Jan;151(1):140-5.

PMID:
16368307
8.

Acetylcysteine and non-ionic isosmolar contrast-induced nephropathy--a randomized controlled study.

Ferrario F, Barone MT, Landoni G, Genderini A, Heidemperger M, Trezzi M, Piccaluga E, Danna P, Scorza D.

Nephrol Dial Transplant. 2009 Oct;24(10):3103-7. doi: 10.1093/ndt/gfp306. Epub 2009 Jun 23.

PMID:
19549691
9.

Is acetylcysteine effective in preventing contrast-related nephropathy? A meta-analysis.

Nallamothu BK, Shojania KG, Saint S, Hofer TP, Humes HD, Moscucci M, Bates ER.

Am J Med. 2004 Dec 15;117(12):938-47.

PMID:
15629733
10.

The role of N--acetylcysteine in the prevention of contrast-induced nephropathy in patients undergoing peripheral angiography: a structured review and meta-analysis.

O'Sullivan S, Healy DA, Moloney MC, Grace PA, Walsh SR.

Angiology. 2013 Nov;64(8):576-82. doi: 10.1177/0003319712467223. Epub 2012 Nov 27. Review.

PMID:
23188834
11.

The role of N-acetylcysteine in preventing radiographic contrast-induced nephropathy.

Guru V, Fremes SE.

Clin Nephrol. 2004 Aug;62(2):77-83. Review.

PMID:
15356963
12.

Sodium bicarbonate therapy for prevention of contrast-induced nephropathy: a systematic review and meta-analysis.

Navaneethan SD, Singh S, Appasamy S, Wing RE, Sehgal AR.

Am J Kidney Dis. 2009 Apr;53(4):617-27. doi: 10.1053/j.ajkd.2008.08.033. Epub 2008 Nov 22. Review.

PMID:
19027212
13.

Meta-analysis: effectiveness of drugs for preventing contrast-induced nephropathy.

Kelly AM, Dwamena B, Cronin P, Bernstein SJ, Carlos RC.

Ann Intern Med. 2008 Feb 19;148(4):284-94. Erratum in: Ann Intern Med. 2008 Aug 5;149(3):219.

PMID:
18283206
14.
15.

Role of N-acetylcysteine in prevention of contrast-induced nephropathy after cardiovascular procedures: a meta-analysis.

Misra D, Leibowitz K, Gowda RM, Shapiro M, Khan IA.

Clin Cardiol. 2004 Nov;27(11):607-10.

16.

High-dose N-acetylcysteine for the prevention of contrast-induced nephropathy.

Trivedi H, Daram S, Szabo A, Bartorelli AL, Marenzi G.

Am J Med. 2009 Sep;122(9):874.e9-15. doi: 10.1016/j.amjmed.2009.01.035.

PMID:
19699385
18.

Intravenous N-acetylcysteine for prevention of contrast-induced nephropathy: a meta-analysis of randomized, controlled trials.

Sun Z, Fu Q, Cao L, Jin W, Cheng L, Li Z.

PLoS One. 2013;8(1):e55124. doi: 10.1371/journal.pone.0055124. Epub 2013 Jan 30.

19.

Acetylcysteine In Diabetes (AID): a randomized study of acetylcysteine for the prevention of contrast nephropathy in diabetics.

Coyle LC, Rodriguez A, Jeschke RE, Simon-Lee A, Abbott KC, Taylor AJ.

Am Heart J. 2006 May;151(5):1032.e9-12.

PMID:
16644332
20.

N-acetylcysteine versus N-acetylcysteine + theophylline for the prevention of contrast nephropathy.

Baskurt M, Okcun B, Abaci O, Dogan GM, Kilickesmez K, Ozkan AA, Ersanli M, Gurmen T.

Eur J Clin Invest. 2009 Sep;39(9):793-9. doi: 10.1111/j.1365-2362.2009.02173.x. Epub 2009 Jun 5.

PMID:
19500141

Supplemental Content

Support Center